These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir. Spangler SK; Jacobs MR; Appelbaum PC Antimicrob Agents Chemother; 1994 Dec; 38(12):2902-4. PubMed ID: 7695280 [TBL] [Abstract][Full Text] [Related]
10. Escherichia coli resistant to cephalosporins and quinolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424. Pace J; Bertasso A; Georgopapadakou NH Antimicrob Agents Chemother; 1991 May; 35(5):910-5. PubMed ID: 1649574 [TBL] [Abstract][Full Text] [Related]
11. In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin. Beskid G; Siebelist J; McGarry CM; Cleeland R; Chan K; Keith DD Chemotherapy; 1990; 36(2):109-16. PubMed ID: 2107064 [TBL] [Abstract][Full Text] [Related]
12. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci. Pankuch GA; Jacobs MR; Appelbaum PC J Antimicrob Chemother; 1995 Jun; 35(6):883-8. PubMed ID: 7559200 [TBL] [Abstract][Full Text] [Related]
13. Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactams. Spangler SK; Jacobs MR; Appelbaum PC J Antimicrob Chemother; 1997 Feb; 39(2):141-8. PubMed ID: 9069533 [TBL] [Abstract][Full Text] [Related]
14. Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae. Goldstein FW Scand J Infect Dis; 1997; 29(3):255-7. PubMed ID: 9255885 [TBL] [Abstract][Full Text] [Related]
15. Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin. Spangler SK; Jacobs MR; Appelbaum PC Antimicrob Agents Chemother; 1994 Apr; 38(4):898-900. PubMed ID: 8031069 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of oral cephalosporins against pediatric isolates of Streptococcus pneumoniae non-susceptible to penicillin, amoxicillin or erythromycin. Fenoll A; Giménez MJ; Robledo O; Aguilar L; Tarragó D; Granizo JJ; Gimeno M; Coronel P J Chemother; 2008 Apr; 20(2):175-9. PubMed ID: 18467242 [TBL] [Abstract][Full Text] [Related]
17. Anti-Brucella activity of Ro 23-9424, a dual-action antibacterial. Qadri SM; Ueno Y; Ayub A Chemotherapy; 1993; 39(6):386-9. PubMed ID: 8222864 [TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of pneumococci to trovafloxacin, penicillin G, and other antimicrobial agents in the Czech Republic and Slovakia. Urbásková P; Trupl J; Hupková H; Appelbaum PC; Jacobs MR Eur J Clin Microbiol Infect Dis; 1996 Aug; 15(8):686-8. PubMed ID: 8894582 [TBL] [Abstract][Full Text] [Related]
19. Susceptibility of penicillin-susceptible and -resistant pneumococci to CFC-222, a new fluoroquinolone. Kim JH; Kang JA; Lee Y; Lee KH; Lee JH; Choi EC; Kim BK J Antimicrob Chemother; 1998 Oct; 42(4):527-30. PubMed ID: 9818754 [TBL] [Abstract][Full Text] [Related]
20. Antipneumococcal activity of BAY 12-8039, a new quinolone, compared with activities of three other quinolones and four oral beta-lactams. Visalli MA; Jacobs MR; Appelbaum PC Antimicrob Agents Chemother; 1997 Dec; 41(12):2786-9. PubMed ID: 9420061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]